Skip to main content
. 2022 Mar 2;23:84. doi: 10.1186/s12882-022-02688-9

Fig. 4.

Fig. 4

LC plasma concentrations for patients after a single oral dose (part 1, n = 20). Pharmacokinetic set 1 included all patients from safety analysis set 1 who had at least one measurable plasma concentration of LC post-dose. Patients with LC plasma concentrations below the lower limit of quantification (0.05 ng/mL) were not included at the respective time points; lower SD error bars have been omitted for clarity

LC lanthanum carbonate, SD standard deviation